US 10738130
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
granted A61KA61K2039/505A61K39/395
Quick answer
US patent 10738130 (Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61K, A61K2039/505, A61K39/395, A61K39/39558, A61K47/6849